2007
DOI: 10.1016/s0140-6736(07)60237-2
|View full text |Cite
|
Sign up to set email alerts
|

Narcolepsy with cataplexy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

16
443
0
21

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 651 publications
(492 citation statements)
references
References 118 publications
16
443
0
21
Order By: Relevance
“…In agreement, noradrenergic neurons cease to discharge for an extended period during REM sleep, as well as during cataplectic episodes (Wu et al,1999), and antidepressants with a preference towards the noradrenaline transporter display anti-cataplectic activity in patients (Baumann et al,2005;Mignot and Nishino, 2005;Dauvilliers et al,2007). Alternatively, the enhanced activation of histaminergic neurons with tiprolisant alone or, even more in association with modafinil, suppresses DREMs as histaminergic neurons also become silent during REM sleep (Vanni-Mercier et al,2003;Takahashi et al,2006) and abolition of HA-synthesis increases REM sleep (Parmentier et al,2002).…”
Section: Discussionmentioning
confidence: 85%
See 2 more Smart Citations
“…In agreement, noradrenergic neurons cease to discharge for an extended period during REM sleep, as well as during cataplectic episodes (Wu et al,1999), and antidepressants with a preference towards the noradrenaline transporter display anti-cataplectic activity in patients (Baumann et al,2005;Mignot and Nishino, 2005;Dauvilliers et al,2007). Alternatively, the enhanced activation of histaminergic neurons with tiprolisant alone or, even more in association with modafinil, suppresses DREMs as histaminergic neurons also become silent during REM sleep (Vanni-Mercier et al,2003;Takahashi et al,2006) and abolition of HA-synthesis increases REM sleep (Parmentier et al,2002).…”
Section: Discussionmentioning
confidence: 85%
“…Modafinil, a drug currently used to decrease EDS in narcolepsy (Mignot and Nishino, 2005;Dauvilliers et al, 2007), enhanced t-MeHA levels to a lower extent (42%) but, when associated to tiprolisant, the effect of the H3 receptor inverse agonist was strongly enhanced (216% activation in orexin-/-mice). Noradrenergic neuron activity, assessed by the 4-hydroxy-3-methoxy-phenylglycol/noradrenaline (MHPG/NA) ratio, was also slightly but not significantly decreased in orexin-/-mice and activated by tiprolisant in both WT and orexin-/-mice (43% and 22%, respectively).…”
Section: Tiprolisant Enhances Histaminergic and Noradrenergic Neuron mentioning
confidence: 99%
See 1 more Smart Citation
“…Both these findings may be interpreted within the framework of the sequential hypothesis of the consolidation function of sleep (Ambrosini and Giuditta, 2001;Giuditta et al, 1995). Indeed, not only was the effectiveness of post-training night lower in NC patients than in normal subjects, but also the lower improvement of consolidation after post-training night in NC patients with SOREM sleep relative to patients without was not balanced over the subsequent six nights, when the numbers of nights with and without SOREM sleep presumably became fairly equivalent in all patients (as SOREM sleep occurs on around half of the nights: Nykamp et al, 1999;Dauvilliers et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Disrupted nighttime sleep is also frequent and should be considered as the fifth narcolepsy symptom. Following the breakthrough discovery of hypocretin deficiency, narcolepsy with cataplexy was recently renamed Narcolepsy Type 1 (NT1, or hypocretin-deficiency syndrome), according to the third edition of the International Classification of Sleep Disorders.…”
Section: Introductionmentioning
confidence: 99%